Hakan Akin
Marmara University
34 Papers
122 Citations
Hakan Akin is an academic researcher from Marmara University. The author has contributed to research in topics: Inflammatory bowel disease & Fatty liver. The author has an hindex of 12, co-authored 34 publications. Previous affiliations of Hakan Akin include Acıbadem University.
Chat about Author
Papers
•Journal Article
Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Veysel Tahan,Billur Canbakan,Huriye Balci,Faysal Dane,Hakan Akin,Güray Can,Ibrahim Hatemi,Vakur Olgaç,Abdullah Sonsuz,Gulsen Ozbay,Ibrahim Yurdakul,Hakan Senturk +11 more
TL;DR: Multinominal logistic regression analysis showed that increased GGT level was a risk factor for advanced fibrosis in NAFLD (OR: 1.0, CI: 0.54-0.94).
98
Diet, microbiota, and colorectal cancer.
Hakan Akin,Nurdan Tözün +1 more
TL;DR: There is strong evidence that reduction of protective bacteria, increase in some bacteria (ie, fusobacterium members; Bacteroides/Prevotella), and age-related changes in microbiota have an impact on adenoma or cancer development.
94
The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
Omer Yanartas,Haluk Tarik Kani,Ercan Biçakci,Irem Kilic,Mutse Banzragch,Cengizhan Acikel,Ozlen Atug,Kemal Kuscu,Nese Imeryuz,Hakan Akin +9 more
TL;DR: In IBD patients having any psychiatric disorder, 6 months of antidepressant drug treatment is associated with an improvement in depression, anxiety, quality of life (QoL), and sexual functioning scores, as well as an improved in Crohn’s disease activity index.
Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats
Veysel Tahan,Veysel Tahan,Ozlen Atug,Hakan Akin,Fatih Eren,Gulgun Tahan,Ozlem Tarcin,Hafize Uzun,Osman Ozdogan,Orhan Tarcin,Nese Imeryuz,Fehmi Ozguner,Cigdem Ataizi Celikel,Erol Avsar,Nurdan Tözün +14 more
TL;DR: The present study suggests that melatonin functions as a potent antioxidant, anti‐inflammatory and antiapoptotic agent in NASH and may be a therapeutic option.
65
Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography
TL;DR: These results hold promise for early noninvasive detection of hepatic steatosis on the basis of CAP assessment and are independently associated with BMI and metabolic syndrome criteria.
36